Grants Awarded



Click on any project title for a more detailed description of the project. For more information about any of these awards (e.g., PI contact information or associated publications), please use the corresponding project number to search for information at the NIH Reporter website. Consistent with NIH policy, abstracts are not available for projects receiving their first award within the past year, so descriptions provided below are from the NCI program director.

New awards will be posted as they are issued.

Year Award Typesort descending Project # RFA # PI/Project Leader Institution Title Status
2008 R43 RFA-CA-07-043 PAMULA, VAMSEE K ADVANCED LIQUID LOGIC MULTIPLEXING CANCER SAMPLE PREPARATION: INDIRECT IMMUNOMAGNETIC ENRICHMENT Complete
1999 R43 PAR-98-066 BEACH, DAVID H. GENETICA, INC. TECHNOLOGIES FOR GENETIC MANIPULATION OF TUMOR CELLS Complete
2005 R43 RFA-CA-05-007 PHILIP, RAMILA IMMUNOTOPE, INC. IDENTIFICATION OF AUTO ANTIGENS IN OVARIAN CANCER Complete
2008 R43 RFA-CA-07-041 KRIZMAN, DAVID BURKE EXPRESSION PATHOLOGY, INC QUANTITATIVE PROTEOMICS OF METASTASIS Complete
1999 R43 PAR-98-066 WINZER-SERHAN, URSULA H AMBION, INC. DEVELOPMENT OF RNA FRIENDLY, HISTOLOGICAL FIXATIVES Complete
2008 R43 RFA-CA-07-041 CHAN, DOUG PROTECH LABORATORIES, INC. DEVELOPMENT AND APPLICATION OF TECHNOLOGY PLATFORM FOR IDENTIFICATION OF THE HIST Complete
2015 R43 PAR-13-327 SELIGMANN, BRUCE E. BIOSPYDER TECHNOLOGIES, INC. IN SITU RNA-FISH WITH LOCALIZED PROFILING BY SEQUENCING FROM FFPE Complete
2008 R43 RFA-CA-07-041 CHENCHIK, ALEX CELLECTA, INC. ARRAY-ASSISTED INSERTIONAL MUTAGENESIS PLATFORM FOR FORWARD GENETICS OF CANCER Complete
2015 R43 PAR-13-327 LELENTAL, MARK CATASSAYS NOVEL ULTRASENSITIVE CANCER BIOMARKER ASSAY PLATFORM UTILIZING PALLADIUM CATALYZED HIGH-GAIN CHEMICAL AMPLIFICATION Complete
2006 R43 RFA-CA-06-006 BEAUDENON, SYLVIE LUCIE AMBION DIAGNOSTICS, INC. ONCOGENIC MICRORNAS IN HPV-INFECTED CERVICAL SAMPLES Complete
2008 R43 RFA-CA-07-039 HANNA, MICHELLE M RIBOMED BIOTECHNOLOGIES, INC. ABSCRIPTION?-BASED CPG METHYLATION ASSAYS FOR EARLY CANCER DETECTION Complete
2011 R43 RFA-CA-10-013 LIM, MARK AMBERGEN, INC GLOBAL PROTEOMIC SCREENING BY MALDI SPECTROMETRIC IMAGING OF PROTEIN-BEAD ARRAYS Complete
2015 R43 PAR-13-327 MANDECKI, WLODEK PHARMASEQ, INC. SEQUENECE-SPECIFIC DETECTION OF PROTEASES USING ELECTRONIC P-CHIPS IN MULTIPLEX FORMAT Complete
2006 R43 RFA-CA-06-005 MOON, JOHN A ILLUMINA, INC. MICROFLUIDIC CAPILLARY ASSAY UTILIZING HOLOGRAPHICALLY * Complete
2008 R43 RFA-CA-07-041 MATHEW, ANU MESO SCALE DIAGNOSTICS, LLC MULTIPLEXED BIOMARKER PANELS FOR EARLY DETECTION OF PROSTATE CANCER Complete
2011 R43 RFA-CA-10-013 RUAN, BIAO POTOMAC AFFINITY PROTEINS, LLC PROTEASE CHAIN REACTIONS FOR MOLECULAR ANALYSIS OF CANCER MARKERS Complete
2015 R43 PAR-13-327 JIANG, LI A'AS, INC. KS-DETECT: A SOLAR-POWERED AND SMARTPHONE INTEGRATED INSTRUMENT FOR POINT-OF-CARE DIAGNOSIS OF KAPOSI'S SARCOMA Complete
2006 R43 RFA-CA-06-005 CAO, HAN BIONANOMATRIX, INC. HIGH RESOLUTION ANALYSIS OF LINEAR GENOMIC DNA IN PARALLEL NANOCHANNEL ARRAYS Complete
2008 R43 RFA-CA-07-039 SQUILLANTE, MICHAEL R RADIATION MONITORING DEVICES, INC. NOVEL DETECTOR FOR MOLECULAR IMAGING STUDIES Complete
2011 R43 RFA-CA-10-013 WARREN, CHRISTOPHER L PROTEOVISTA, LLC HIGH THROUGHPUT METHOD TO ASSESS SNP FUNCTIONALITY IN PROSTATE CANCER Complete
2015 R43 PAR-13-327 TRAN, HIEP T ABZYME THERAPEUTICS, LLC HYBRIDOMA FREE MULTIPLEX APPROACH FOR ACCELERATING MOUSE MONOCLONAL ANTIBODY GENERATION Complete
2006 R43 RFA-CA-06-006 LEE, PHILIP J CELLASIC CORPORATION MICROFLUIDIC SYSTEM FOR AUTOMATED CELL TOXICITY SCREENING Complete
2008 R43 RFA-CA-07-039 HAHN, KRISTINE K PERSCITUS BIOSCIENCES, LLC SINGLET OXYGEN-MEDIATED PROTEIN PROXIMITY ASSAY Complete
2011 R43 RFA-CA-10-013 MORACHIS, JOSE MANUEL NANOCELLECT BIOMEDICAL, INC. ADING COLOR TO CANCER, ADENOVIRUS AND FLOW CYTOMETRY TO IDENTIFY AND CAPTURE CTCS Complete
2015 R43 PAR-13-327 MESSMER, BRADLEY T ABREOS BIOSCIENCES, INC. MULTIPLEXED DENANO PROTEIN ASSAY AND QUANTITATION: SEQUENCING BASED PROTEOMICS Complete
2008 R44 RFA-CA-07-039 GUO, BAOCHUAN GLC BIOTECHNOLOGY, INC. MMPA: A NOVEL MULTIPLEXING METHYLATION ANALYSIS TECHNOLOGY Complete
2006 R44 RFA-CA-06-006 BROWN, DAVID M AMBION DIAGNOSTICS, INC. MIRNA PROFILING IN FIXED CANCER SAMPLES Complete
2008 R44 RFA-CA-07-041 LEE, BRIAN W IMMUNOCHEMISTRY TECHNOLOGIES, LLC NEW FLUORESCENT CASPASE DETECTION PROBES TO LABEL APOPTOTIC TUMOR CELLS IN VIVO Complete
2006 R44 RFA-CA-06-005 BRADY, ERIK D MICROCOSM, INC. ENHANCED CANCER MICROARRAY Complete
2008 R44 RFA-CA-07-039 LIM, MARK AMBERGEN, INC ADVANCED TECHNOLOGY FOR ASSAYING CANCER-DRUG RESISTANCE Complete
2006 R44 RFA-CA-06-005 LU, PETER S. ARBOR VITA CORPORATION A NOVEL DIAGNOSTIC ASSAY FOR ONCOGENIC HUMAN PAPILLOMAVIRUSES Complete
2020 R44 PAR-18-303 FRIEDA, KIRSTEN SPATIAL GENOMICS, INC. Spatial and single cell analysis of tumor microenvironment by seqFISH+ Complete
2008 R44 RFA-CA-07-041 LEE, PHILIP J CELLASIC CORPORATION MICROFLUIDIC PLATFORM FOR CANCER CELL CULTURE AND ANALYSIS Complete
2008 R44 RFA-CA-06-006 BROWN, DAVID M AMBION DIAGNOSTICS, INC. MIRNA PROFILING IN FIXED CANCER SAMPLES Complete
2008 R44 RFA-CA-07-008 DOLINGER, DAVID LEE IQUUM, INC. RAPID POINT-OF-CARE ASSAY FOR DETECTING HIGH RISK HUMAN PAPILLOMAVIRUS Complete
2021 R44 PAR-18-303 HUNG, PAUL JU-SUNG COMBINATI, INC. Digital Melt Curve Analysis Platform for Longitudinal Cancer Patient Monitoring Complete
2016 R44 PAR-13-327 KARSTEN, STANISLAV NEUROINDX INC. Automated Platform for Fixed Tissue Microdissection Complete
2020 R44 PAR-18-303 GURARD-LEVIN, ZACHARY SAMDI TECH, INC. Development Of The First Label-free And High-throughput, Cell-based Assay That Reports On Specific Enzyme Activities Complete
2016 R44 PAR-13-327 JOHNSON, DAVID SCOTT GIGAGEN, INC. Next-Generation Antibody Discovery and Development Technology Complete
2004 R44 PAR-01-106 TS'O, PAUL O. P. CCC DIAGNOSTICS, LLC CLINICAL STUDIES OF CIRCULATING EPITHELIAL CANCER CELLS Complete
2009 R44 RFA-CA-08-011 CHEN, WEN-TIEN VITATEX, INC. CANCER PROGENIYOR CELL MARKERS Complete
2001 R44 PAR-99-101 CHEE, MARK S. ILLUMINA, INC. RANDOM ARRAYS FOR GENE EXPRESSION PROFILING Complete
2004 R44 PAR-01-105 BALGLEY, BRIAN M CALIBRANT BIOSYSTEMS, INC. INTEGRATED TOP-DOWN/BOTTOM-UP COMPREHENSIVE PROTEOMICS Complete
2009 R44 RFA-CA-08-013 ZOU, NIANXIANG BIO-QUICK CORPORATION DEVELOPMENT OF ULTRASOUND-FACILITATED FORMALIN-FIXED AND PARAFFIN-EMBEDDED TISSUE Complete
2020 R44 PAR-18-303 LIM, MARK AMBERGEN, INC Highly Multiplexed Nanoscale Mass Spectrometric Imaging Of Cancer Tissues Complete
2001 R44 PAR-99-101 BITTER, GRANT A. BITTECH, INC. DNA MISMATCH REPAIR FUNCTIONAL GENETIC TESTS Complete
2004 R44 PAR-01-105 ZEBALA, JOHN A SYNTRIX BIOSYSTEMS, INC. ARTIFICIAL ANTIBODY MIMETICS Complete
2009 R44 RFA-CA-07-010 LEVENSON, RICHARD M. CAMBRIDGE RESEARCH AND INSTRUMENTATION CELLULARLY RESOLVED MOLECULAR PATHWAY ASSESSMENT IN BIOPSIES VIA SPECTRAL IMAGING Complete
2001 R44 PAR-99-101 GITE, SADANAND AMBERGEN, INC NOVEL TECHNOLOGY FOR THE ANALYSIS OF GENE EXPRESSION Complete
2004 R44 PAR-01-105 ZEBALA, JOHN A SYNTRIX BIOSYSTEMS, INC. INSTRUMENTATION FOR HIGH-RESOLUTION ANALYSIS OF CANCER Complete

Pages